Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation
暂无分享,去创建一个
J. Baert | B. Foveau | J. Coll | D. Tulasne | C. Leroy | B Foveau | V. Fafeur | V Fafeur | J Coll | Z Ji | C Degerny | N Vintonenko | J Deheuninck | C Leroy | D Tulasne | J-L Baert | C. Degerny | N. Vintonenko | J. Deheuninck | Z. Ji
[1] Zhengxin Wang,et al. SENP1 Enhances Androgen Receptor-Dependent Transcription through Desumoylation of Histone Deacetylase 1 , 2004, Molecular and Cellular Biology.
[2] F. J. Herrera,et al. Molecular Biology: What Ubiquitin Can Do for Transcription , 2004, Current Biology.
[3] B. Vandenbunder,et al. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. , 1999, Molecular biology of the cell.
[4] L. McIntosh,et al. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] N. Muthusamy,et al. Defective activation and survival of T cells lacking the Ets-1 transcription factor , 1995, Nature.
[6] B. Wasylyk,et al. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2 , 1997, Oncogene.
[7] R. Hay,et al. SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting* , 2001, The Journal of Biological Chemistry.
[8] G. Blobel,et al. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex , 1996, The Journal of cell biology.
[9] R. Hay,et al. Ubch9 conjugates SUMO but not ubiquitin , 1997, FEBS letters.
[10] J. Iñiguez-Lluhí,et al. A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.
[11] A. Ciechanover,et al. The ubiquitin system. , 1998, Annual review of biochemistry.
[12] R. Hay,et al. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.
[13] Erica S. Johnson,et al. Protein modification by SUMO. , 2004, Annual review of biochemistry.
[14] Toshiyuki Yamada,et al. Molecular biology of the Ets family of transcription factors. , 2003, Gene.
[15] T. Saruta,et al. Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription* , 2005, Journal of Biological Chemistry.
[16] A. Dejean,et al. Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.
[17] B. Vandenbunder,et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.
[18] Min Wang,et al. The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.
[19] R. Sood,et al. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] Jürgen Dittmer,et al. Molecular Cancer BioMed Central Review The Biology of the Ets1 Proto-Oncogene , 2003 .
[21] A. Dejean,et al. FLI-1 Functionally Interacts with PIASxα, a Member of the PIAS E3 SUMO Ligase Family* , 2005, Journal of Biological Chemistry.
[22] S. Müller,et al. SUMO: a regulator of gene expression and genome integrity , 2004, Oncogene.
[23] F. Alt,et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene , 1995, Nature.
[24] B. Wasylyk,et al. Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme , 1997, Oncogene.
[25] Y. De Launoit,et al. Inhibition of JNK by HGF/SF Prevents Apoptosis Induced by TNF‐α , 2003, Annals of the New York Academy of Sciences.
[26] B. Wasylyk,et al. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net , 2005, Oncogene.
[27] R. Dohmen. SUMO protein modification. , 2004, Biochimica et biophysica acta.
[28] S. Müller,et al. PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.
[29] D. Glossip,et al. Sumoylation of LIN-1 promotes transcriptional repression and inhibition of vulval cell fates , 2005, Development.
[30] P. Mehlen,et al. Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage , 2004, Molecular and Cellular Biology.
[31] Y. Totsuka,et al. E1AF degradation by a ubiquitin-proteasome pathway. , 2005, Biochemical and biophysical research communications.
[32] G. Blobel,et al. Ubc9p Is the Conjugating Enzyme for the Ubiquitin-like Protein Smt3p* , 1997, The Journal of Biological Chemistry.
[33] L. McIntosh,et al. Solution structure of the ETS domain from murine Ets‐1: a winged helix‐turn‐helix DNA binding motif. , 1996, The EMBO journal.
[34] M. Crossley,et al. Role for SUMO Modification in Facilitating Transcriptional Repression by BKLF , 2005, Molecular and Cellular Biology.
[35] K. Bohren,et al. A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.
[36] A. Sharrocks,et al. PIASx acts as an Elk‐1 coactivator by facilitating derepression , 2005, The EMBO journal.
[37] J. Baert,et al. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors , 1998, Oncogene.
[38] H. Saitoh,et al. Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.
[39] G. V. Vande Woude,et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] Ivan Dikic,et al. Ubiquitylation and cell signaling , 2005, The EMBO journal.
[41] R. Hay,et al. SUMO: a history of modification. , 2005, Molecular cell.
[42] D. Monté,et al. SUMO Modification of the Ets-related Transcription Factor ERM Inhibits Its Transcriptional Activity* , 2005, Journal of Biological Chemistry.
[43] Andrew D Sharrocks,et al. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. , 2003, Molecular cell.
[44] Boris Pfander,et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.